Improving lung cancer treatment decisions and patient quality of life
Optimizing treatment decisions and quality-adjusted life years through improved lung cancer staging
This study is looking at two different ways to take samples from lymph nodes in patients with early to mid-stage lung cancer to see which method helps doctors make better treatment decisions and improve patient outcomes.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10899827 on NIH RePORTER |
What this research studies
This research investigates how two different biopsy procedures, endobronchial ultrasound guided transbronchial node aspiration (EBUS) and mediastinoscopy, can affect treatment decisions for patients with stage I-III non-small cell lung cancer (NSCLC). By comparing these methods, the study aims to determine which procedure better detects the extent of cancer spread to lymph nodes and how this impacts patient outcomes. The research will utilize data from approximately 2,200 patients to analyze the effectiveness and risks associated with each procedure, ultimately aiming to enhance the quality-adjusted life years for patients. Patients will be monitored for changes in treatment decisions based on the biopsy results.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with stage I-III non-small cell lung cancer who require lymph node staging.
Not a fit: Patients with advanced lung cancer beyond stage III or those who are not candidates for biopsy procedures may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment decisions and better quality of life for lung cancer patients.
How similar studies have performed: Previous research has shown promising results in improving treatment outcomes through enhanced staging techniques, indicating that this approach may yield significant benefits.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Rudasill, Sarah Elizabeth — Massachusetts General Hospital
- Study coordinator: Rudasill, Sarah Elizabeth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.